Results 51 to 60 of about 47,826 (261)
Sydenham's chorea: clinical and evolutive characteristics
São Paulo Medical Journal, 2002 CONTEXT: During the last 12 years we have observed an increase in the frequency of Sydenham's chorea in our country. We have observed that some of our patients have presented recurrence of the chorea despite regular treatment with benzathine penicillin ...
Maria Teresa Ramos Ascensão Terreri +5 more
doaj +1 more source
Neuroacanthocytosis: a case report of chorea-acanthocytosis [PDF]
Journal of Integrative Neuroscience, 2019 Neuroacanthocytosis is a rare progressive neurodegenerative disease, including chorea-acanthocytosis, McLeod syndrome, Huntington’s disease-like 2, and pantothenate kinase-associated neurodegeneration, where chorea-acanthocytosis occupies the main entity
Yuanyuan Xiang, Shan Li, Xiaohui Liu, Jifeng, Li, Qinjian, Sun, Yan, Chen, Yifeng Du, Junwei Wu
doaj +1 more source
BioEssays, EarlyView.Recent findings indicate that mitochondria‐associated membranes (MAMs), where the endoplasmic reticulum directly contacts the mitochondria, are a novel microdomain essential for cellular homeostasis, including proteostasis. We summarize the disruption of protein homeostasis and MAM alteration in neurodegenerative diseases, then discuss challenges and ...
Seiji Watanabe, Koji Yamanaka
wiley +1 more source
Antiphospholipid-related chorea
Frontiers in Neurology, 2012 Chorea is a movement disorder which may be associated with immunologic diseases, in particular in the presence of antiphospholipid antibodies (aPL). Choreic movements have been linked to the isolated presence of plasmatic aPL, or to primary or secondary ...
Silvio ePeluso +6 more
doaj +1 more source
The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician [PDF]
, 2013 A growing number of progressive heredodegenerative conditions mimic the presentation of Huntington's disease (HD). Differentiating among these HD-like syndromes is necessary when a patient with a combination of movement disorders, cognitive decline ...
Bhatia, KP, Martino, D, Stamelou, M
core
GNAO1 encephalopathy: broadening the phenotype and evaluating treatment and outcome [PDF]
, 2017 OBJECTIVE: To describe better the motor phenotype, molecular genetic features, and clinical course of GNAO1-related disease. METHODS: We reviewed clinical information, video recordings, and neuroimaging of a newly identified cohort of 7 patients ...
Bianchini, C +20 more
core +3 more sources
Clinical Pharmacology &Therapeutics, EarlyView.Although attractive for relevance to real‐world scenarios, real‐world data (RWD) is typically used for drug repurposing and not therapeutic target discovery. Repurposing studies have identified few effective options in neurological diseases such as the rare disease, amyotrophic lateral sclerosis (ALS), which has no disease‐modifying treatments ...
Mohammadali Alidoost +9 more
wiley +1 more source
Postanoxia-Induced Chorea Treated with Intravenous Fentanyl
Case Reports in Neurological Medicine, 2023 The case presented is that of a young male with postanoxic brain injury secondary to cocaine overdose who began to exhibit choreiform movements of the left upper extremity.
Ashley Audi +2 more
doaj +1 more source
Ueber Chorea chronica progressiva (Huntington'sche Chorea, Chorea hereditaria) [PDF]
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, 1888 n ...
openaire +2 more sources
Late onset of Huntington's disease [PDF]
, 1985 Twenty-five patients with late-onset Huntington's disease were studied; motor impairment appeared at age 50 years or later. The average age at onset of chorea was 57.5 years, with an average age at diagnosis of 63.1 years.
Myers, R. H. +7 more
core